[Theoretical grounds of a trend of pathogenetic therapy of tuberculosis].
D004950:Esterases / Q000627:therapeutic use; D005174:Factor XII / Q000502:physiology; D005341:Fibrinolysin / Q000502:physiology; D005342:Fibrinolysis; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000097:blood / Q000150:complications / Q000188:drug therapy; D007249:Inflammation / Q000209:etiology; D007705:Kinins / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000097:blood; D011480:Protease Inhibitors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D000515:alpha 1-Antitrypsin / Q000627:therapeutic use; D000511:alpha-Macroglobulins
D007705:Kinins; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D005174:Factor XII; D004950:Esterases; D005341:Fibrinolysin
Teoreticheskie predposyliki odnogo iz napravleniĭ patogeneticheskoĭ terapii tuberkuleza